Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Shenzhen Hepalink Pharma (002399 CH)
Watchlist
85
Analysis
Health Care
•
China
Shenzhen Hepalink Pharmaceutical Co., Ltd researches, produces and sells heparin pharmaceuticals products. The Company's products include heparin sodium active pharmaceutical ingredient.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Quantitative Analysis
•
16 Jan 2023 08:20
A-H Premium Weekly (Jan 13th): Fuyao Glass, Shenhua, Minsheng, Yankuang Energy, China Longyuan
We analyzed A-H premium changes in the past week and highlight A-H premium changes for Fuyao Glass, Shenhua, Minsheng, Yankuang Energy, China...
Ke Yan, CFA, FRM
Follow
467 Views
Share
bearish
•
Quantitative Analysis
•
06 Nov 2022 14:03
A-H Premium Weekly (Nov 4th): First Tractor, Maanshan Iron
We analyzed A-H premium changes in the past week and highlight A-H premium changes for First Tractor, Maanshan Iron, Datang Intl, Cansino, Jushi,...
Ke Yan, CFA, FRM
Follow
304 Views
Share
bullish
•
Shenzhen Hepalink Pharmaceutical
•
07 Jul 2020 16:08
Hepalink Pharma IPO: Trading Debut
Shenzhen HepaLink Pharmaceuticals (H) (HEPALINK HK) is a leading China-based pharmaceutical company with global businesses in pharmaceutical,...
Arun George
Follow
528 Views
Share
bullish
•
Shenzhen Hepalink Pharmaceutical
•
23 Jun 2020 19:20
Hepalink Pharma IPO: Valuation Insights
Shenzhen HepaLink Pharmaceuticals (H) (HEPALINK HK) is a leading China-based pharmaceutical company with global businesses in pharmaceutical,...
Arun George
Follow
648 Views
Share
bullish
•
Shenzhen Hepalink Pharmaceutical
•
23 Jun 2020 13:06
Shenzhen Hepalink (海瑞普) A+H: Hot Deal that Might Not Fly
Shenzhen Hepalink, a leading heparin manufacturer in China, launched book building to raise up to USD 585 million to list in Hong Kong. In our...
Ke Yan, CFA, FRM
Follow
602 Views
Share
First
Previous
12
13
14
15
16
17
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x